iShares MSCI EAFE International Index Fund
BlackRock Index Funds, Inc. · Series S000003116
data updated 2026-09-08
Fund profile
As filed in the prospectus · 2026 Q2
The investment objective of iShares MSCI EAFE International Index Fund ( MSCI EAFE International Index Fund or the Fund ), a series of BlackRock Index Funds, Inc. (the Corporation ), is to match the performance of the MSCI EAFE Index (Europe, Australasia, Far East) (the MSCI EAFE Index or the Underlying Index ) in U.S. dollars with net dividends as closely as possible before the deduction of Fund expenses.
The fund employs a passive strategy to track the MSCI EAFE Index, investing in a statistically selected sample of equity securities across all countries represented in the index rather than holding every constituent. Because the fund samples the index rather than replicating it exactly, its performance may diverge from the index.
| Share class | Expense ratio |
|---|---|
| C000008447 | 0.34% |
| C000008448 | 0.09% |
| C000099168 | 0.04% |
| C000201956 | 0.34% |
| C000244427 | 0.03% |
Portfolio turnover 8.00% · as of 2026 Q2
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 98.23% |
| Cash & short-term | 0.97% |
| Derivatives | 0.02% |
| Other | 0.00% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: Resonac Holdings Corp, Furukawa Electric Co Ltd, Telecom Italia SpA/Milano, Mitsui Kinzoku Co Ltd, Enlight Renewable Energy Ltd, PLS Group Ltd, Millicom International Cellular SA, Wise Group PLC
Largest exited: Wise PLC, Telecom Italia SpA/Milano, Nice Ltd, Tokyu Corp, Sekisui Chemical Co Ltd, Shimadzu Corp, Sony Financial Group Inc, MatsukiyoCocokara & Co
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
This fund changed legal form during the period shown. The history above is continuous — it spans both eras, and the change is not a gap in reporting.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| — | ASML Holding NV | 3.49% | $1,980.18 | $486.91M | 245.9K |
| — | HSBC Holdings PLC | 1.48% | $18.91 | $205.84M | 10.9M |
| — | Roche Holding AG | 1.31% | $411.09 | $182.96M | 445.1K |
| — | Novartis AG | 1.30% | $156.29 | $181.32M | 1.2M |
| — | AstraZeneca PLC | 1.28% | $186.70 | $178.86M | 958.0K |
| — | Nestle SA | 1.20% | $102.57 | $167.41M | 1.6M |
| — | Siemens AG | 1.08% | $321.51 | $151.31M | 470.6K |
| — | Shell PLC | 0.99% | $38.85 | $138.23M | 3.6M |
| — | Tokyo Electron Ltd | 0.99% | $484.85 | $137.64M | 283.9K |
| — | Mitsubishi UFJ Financial Group Inc | 0.97% | $19.92 | $134.81M | 6.8M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 14.09% of net assets, top 25 25.72%, across 674 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free